Routine usage of potassium-sparing agent (spironolactone, eplerenone, or amiloride), angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker to ameliorate hypokalemia is not recommended because these medications can exacerbate renal salt wasting and polyuria (20, 35). Here, ACE is linked to Polyuria.